
Overview
I am a radiation oncologist, and I primarily focus on treating patients with cancer of the brain, lung, and spine. I find great satisfaction meeting with patients and working to provide the best care possible. During our visits, I enjoy getting to know patients and their families and learning about their hobbies, interests, and values. Working together, my goal is provide the tools and understanding so that they feel comfortable in making treatment decisions. I have the privilege of being a part of an excellent team of doctors, nurses, therapists, and treatment planners, who all work to design and carry out a personalized treatment plan for each patient. Outside of the clinic, I enjoy spending time with my family and friends.
Dr. Mullikin is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma.
Dr. Mullikin is board certified in American Board Of Radiology, Radiation Oncology. He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 1 clinical trial.
Graduate Institution
Residency
Specialties
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Private Diagnostic Clinic PLLC
David Kirsch is a Radiation Oncologist practicing medicine in Durham, North Carolina. Dr. Kirsch is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxoid Liposarcoma, Rhabdomyosarcoma, and Tissue Biopsy.
Duke University Health System Inc
Erik Sulman is a Radiation Oncologist practicing medicine in Durham, North Carolina. Dr. Sulman is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Gliomatosis Cerebri, and Gamma Knife Radiosurgery.
Duke Cancer Center
I'm a radiation oncologist, and I specialize in treating brain, base of skull and spine tumors, as well as tumors that arise in the body but go to the brain or the spine, as in certain cases of lung, breast and kidney cancer and melanoma. When I meet with a patient, it’s important for me to introduce them and their family to our team of doctors, therapists, nurses and treatment planners. The patient and their family will also become members of this team – truly the most important part - so we can work together to tailor care based on their wants and needs. At Duke, we’ve developed techniques to precisely and accurately treat small, complex lesions and tumors. We can minimize the amount of radiation that goes into normal tissues and at the same time maximize the amount of radiation where it is needed. Our team is geared to delivering every treatment to each patient exactly as planned, especially in complicated and difficult situations. As a patient or a physician, I think there’s no better place to be than Duke. I love my work, feel honored that my patients place their trust in our team and me and work hard to earn that trust. Dr. Kirkpatrick is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Meningioma, Glioma, Astrocytoma, and Gamma Knife Radiosurgery. Dr. Kirkpatrick is board certified in American Board Of Radiology, Radiation Oncology.
Frequently Asked Questions about Dr. Trey C. Mullikin
How do I make an appointment with Dr. Trey C. Mullikin?
You can book an appointment with Dr. Trey C. Mullikin by calling their office at 919-681-6900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Trey C. Mullikin a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Trey C. Mullikin is classified as an Distinguished expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Trey C. Mullikin specialize in?
While Dr. Trey C. Mullikin is a Radiation Oncology, they have specific expertise in Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Trey C. Mullikin participate in research or clinical trials?
Yes. Dr. Trey C. Mullikin has published 51 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Trey C. Mullikin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Trey C. Mullikin accept my insurance?
Dr. Trey C. Mullikin accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-681-6900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Mullikin isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Large-Cell Lung CarcinomaDr. Mullikin isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Mullikin isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Mullikin isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Mullikin isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Mullikin isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- EGFR Positive Lung CancerDr. Mullikin isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Mullikin isAdvanced. Learn about Lung Cancer.
- Metastatic Brain TumorDr. Mullikin isAdvanced. Learn about Metastatic Brain Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Mullikin isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Posterior Fossa TumorDr. Mullikin isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- AngiosarcomaDr. Mullikin isExperienced. Learn about Angiosarcoma.
- Angiosarcoma of the ScalpDr. Mullikin isExperienced. Learn about Angiosarcoma of the Scalp.
- AstrocytomaDr. Mullikin isExperienced. Learn about Astrocytoma.
- Ataxia-TelangiectasiaDr. Mullikin isExperienced. Learn about Ataxia-Telangiectasia.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Mullikin isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Bone TumorDr. Mullikin isExperienced. Learn about Bone Tumor.
